Epidiolex Approved by the FDA for Epilepsy

Epidiolex Approved by the FDA for Epilepsy

Monday, June 25th, U.S. Food & Drug Administration (FDA) approved EPIDIOLEX®(cannabidiol) oral solution for the treatment of seizures associated with two severe epilepsy syndromes known as Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age or...
Cannabidiol (CBD) and HH

Cannabidiol (CBD) and HH

For approximately one third of people with epilepsy, their seizures cannot be controlled with the current regimen of anti-epileptic drugs (AEDs). Hypothalamic Hamartomas are no exception to this statistic. Studies are on-going to test the efficacy of cannabidiol, or...